Sandu Pharmaceuticals informs about disclosure

25 Feb 2023 Evaluate

Sandu Pharmaceuticals has informed that it enclosed Trading Approval Letter received from BSE pertaining to application made by Company in respect of the Trading of 8,50,326 equity shares of Rs 10 each to be issued at premium of Rs 10.69 bearing distinctive numbers from 8810665 to 9660990 issued to Promoter and Non-Promoters on a preferential basis pursuant to conversion of 8,50,326 warrants.

The above information is a part of company’s filings submitted to BSE.

Sandu Pharmaceutical Share Price

33.15 -0.65 (-1.92%)
06-Feb-2026 12:05 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1694.80
Dr. Reddys Lab 1233.90
Cipla 1328.10
Zydus Lifesciences 888.60
Lupin 2180.35
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×